Can a cancer vaccine shield transplant patients from HPV?
NCT ID NCT03023631
Summary
This study is testing how well the Gardasil 9 vaccine works to prevent HPV infection in cancer patients who have received a donor stem cell transplant. Researchers are giving the vaccine to 48 adult patients 6-12 months after their transplant to see if their immune systems can build strong, lasting protection against HPV. The main goal is to measure the antibody response and check the vaccine's safety in this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.